Approval · Notice of Compliance 14684 · 2013
IMODIUM COMPLETE CAPLETS: Notice of Compliance 14684
Issued August 27, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14684
- Date
- August 27, 2013
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product name change
- Therapeutic class
- Antidiarrheal - antiflatulent agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMODIUM COMPLETE CAPLETS | 02245185 | Marketed |
| IMODIUM COMPLETE CHEWABLE TABLETS | 02237297 | Cancelled Post Market |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB
- SIMETHICONE 125 MG per TAB